Cerus Q3 product revenue $46.0M (+16% YoY); raises FY2024 guidance to $177-179M

CERUS CORP

2024-Q3 EPS reported -$0.10

Net loss narrowed to $2.9M ($0.02/sh) from $7.3M; positive non-GAAP adjusted EBITDA of $4.4M.
Product revenue guidance raised to $177-179M from $175-178M; IFC guidance raised to $9-10M.
Signed new 6-year BARDA contract up to $248M for INTERCEPT RBC advancement through PMA licensure.
CE Mark review for INTERCEPT RBCs denied; assessing strategy for resubmission with TÜV-SÜD.
Generated positive operating cash flow for third straight quarter; cash & investments $75.6M at Q3 end.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.